The present invention relates to crystalline etanercept and to methods of making crystalline etanercept; to pharmaceutical compositions comprising crystalline etanercept; and to therapeutic uses of such compositions.

 
Web www.patentalert.com

> CB1 antagonist compounds

~ 00380